home / lobbying

lobbying_activities

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

274 rows where filing_period = "second_quarter", filing_year = 2017 and issue_code = "MED" sorted by filing_year descending

✎ View and edit SQL

This data as json, CSV (advanced)

Suggested facets: filing_type, income_amount, is_termination, received_date (date)

issue_code 1

  • MED · 274 ✖

filing_year 1

  • 2017 · 274 ✖

filing_period 1

  • second_quarter · 274 ✖
id filing_uuid filing_type registrant_name registrant_id client_name filing_year ▲ filing_period issue_code specific_issues government_entities income_amount expense_amount is_no_activity is_termination received_date
1982016 BOCKORNY GROUP, INC. c3ffade5-2e08-4932-b30d-072d66d652f0 2T BOCKORNY GROUP, INC. 289773 BLACK BERET LIFE SCIENCES LLC (FORMERLY REPORTING AS BOSARGE LIFE SCIENCES) 2017 second_quarter MED Issues related to the 21st Century Cures Initiative Issues related to FDA reform HOUSE OF REPRESENTATIVES,SENATE 25000   0 1 2017-06-08T15:39:48.427000-04:00
1982470 MR. BRIAN KELLY d2cc2ae5-ba0f-4bce-9180-c6aa128f2d9a Q2 MR. BRIAN KELLY 40024191 INTELLIA THERAPEUTICS 2017 second_quarter MED Gene Editing Defense Advanced Research Projects Agency (DARPA),Executive Office of the President (EOP),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),Natl Science Foundation (NSF),SENATE,White House Office 15000   0 0 2017-06-30T10:54:11.893000-04:00
1982475 MR. BRIAN KELLY 3055e158-1468-402f-adf1-3fce81115852 Q2 MR. BRIAN KELLY 40024191 LUNDBECK PHARMACEUTICALS 2017 second_quarter MED Brain Disorders CNS Alzheimer's HOUSE OF REPRESENTATIVES,SENATE 15000   0 0 2017-06-30T10:55:16.673000-04:00
1982609 MARSHALL BRACHMAN 6bf295e8-35d6-407f-b7cb-22ef739c8e12 Q2 MARSHALL BRACHMAN 6848 BAYLOR SCOTT AND WHITE HEALTH -- FORMERLY BAYLOR HEALTH CARE SYSTEM 2017 second_quarter MED support funding for medical research programs HOUSE OF REPRESENTATIVES,SENATE 33000   0 0 2017-07-01T17:04:48.950000-04:00
1982921 FRANCIS EDWARD & CRONIN, INC. 1829108b-2fb7-4169-be72-e409790ec844 Q2 FRANCIS EDWARD & CRONIN, INC. 311314 CURE ALZHEIMER'S FUND 2017 second_quarter MED Legislation related to Alzheimer's disease research. HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 20000   0 0 2017-07-04T21:04:49.333000-04:00
1983389 AMERICAN COLLEGE OF CLINICAL PHARMACY 55f83551-dc10-499b-87c1-0eb70db2ca35 Q2 AMERICAN COLLEGE OF CLINICAL PHARMACY 57258 AMERICAN COLLEGE OF CLINICAL PHARMACY 2017 second_quarter MED Focus interactions with the Agency for Healthcare Research and Quality (AHRQ) on the issue of Quality of Medication Therapy Management Services delivered programs authorized by the Patient Protection and Affordable Care Act (PPACA PL 111-148) and Medicare Part D plans. Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE   128375 0 0 2017-07-06T12:18:21.283000-04:00
1983473 NATIONAL BREAST CANCER COALITION FUND b1edc0f7-4e6b-43ef-be76-e1ed8394cf7f Q2 NATIONAL BREAST CANCER COALITION FUND 52652 NATIONAL BREAST CANCER COALITION FUND 2017 second_quarter MED HR 1628, the American Health Care Act. Reforming parts of the ACA. Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Defense Advanced Research Projects Agency (DARPA),Defense, Dept of (DOD),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,White House Office   62251 0 0 2017-07-06T14:26:43.343000-04:00
1983538 UC HEALTH ca5c2b40-568f-4ba1-bf86-376e0791bcda Q2 UC HEALTH 401103195 UC HEALTH 2017 second_quarter MED NIH Funding HOUSE OF REPRESENTATIVES,SENATE     0 0 2017-07-06T15:25:53.500000-04:00
1983821 MICHAEL N. MCCARTY LAW OFFICE PLLC 201eea9a-037a-48ea-b827-92731887ee6b Q2 MICHAEL N. MCCARTY LAW OFFICE PLLC 401104300 AMERICAN MEDICAL TECHNOLOGISTS 2017 second_quarter MED Regulation of Laboratory Developed Tests; Funding for harmonization of diagnostic test results; House and Senate legislation to repeal and replace or amend the Affordable Care Act, particularly as such legislation may affect access to clinical laboratory services. Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2017-07-07T10:52:10.747000-04:00
1983928 JENNIE AYLWARD a39da428-6f74-4d84-adbe-d567fc713f67 2T JENNIE AYLWARD 401104208 PINK RIBBON RED RIBBON 2017 second_quarter MED Requested support for the U.S. Governments contributions to fight women's cancers in low- and middle-income countries with robust funding for the National Institutes of Health (especially the National Cancer Institute) in FY2018 Labor/HHS/Education appropriations. HOUSE OF REPRESENTATIVES,SENATE,U.S. Agency for International Development (USAID) 10000   0 1 2017-07-07T13:29:51.900000-04:00
1983976 CURATORS OF THE UNIVERSITY OF MISSOURI c29437b0-d688-4d5a-95be-99ee11e5fc86 Q2 CURATORS OF THE UNIVERSITY OF MISSOURI 43616 CURATORS OF THE UNIVERSITY OF MISSOURI 2017 second_quarter MED Issues relating to F&A rates for universities. HOUSE OF REPRESENTATIVES,SENATE   80000 0 0 2017-07-07T14:18:28.747000-04:00
1984236 NATURAL RESOURCE RESULTS LLC 1403b162-bd2f-4602-94b4-1a6955edb87a Q2 NATURAL RESOURCE RESULTS LLC 321555 SHINE MEDICAL TECHNOLOGIES 2017 second_quarter MED Support lifting cap on NNSA program for medical isotope production under AMIPA; support funding SHINE facility under same program at NNSA in FY17 approps and FY18 budget and approps. Council on Environmental Quality (CEQ),Energy, Dept of,HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE,White House Office 20000   0 0 2017-07-09T19:36:57.933000-04:00
1984511 WAKE FOREST UNIVERSITY HEALTH SCIENCES 20d5b42c-4a2b-4945-8ea6-7fa66c781c92 Q2 WAKE FOREST UNIVERSITY HEALTH SCIENCES 6781 WAKE FOREST UNIVERSITY HEALTH SCIENCES 2017 second_quarter MED VA Research funding Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE   130000 0 0 2017-07-10T14:18:14.870000-04:00
1984591 ALZHEIMER'S FOUNDATION OF AMERICA 0e0d50c4-0cbb-4fc9-b94b-f579f8ca364b Q2 ALZHEIMER'S FOUNDATION OF AMERICA 323158 ALZHEIMER'S FOUNDATION OF AMERICA 2017 second_quarter MED S. 445 - the Home Health Care Planning Improvement Act of 2017 S. 464 - Independence at Home Act of 2017 H.R. 1825, Home Health Care Planning Act Administration on Aging,Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE,White House Office   30000 0 0 2017-07-10T14:53:16.110000-04:00
1985031 MARSHFIELD CLINIC HEALTH SYSTEM 5e231365-9255-4d8c-aafb-be5807644fd2 Q2 MARSHFIELD CLINIC HEALTH SYSTEM 57830 MARSHFIELD CLINIC HEALTH SYSTEM 2017 second_quarter MED MED (Medical Disease Research/ Clinical Labs) Protecting Access to Medicare Act of 2014 (PAMA) PAMA includes reforms to the Clinical Lab Fee Schedule (CLFS). This rule for PAMA requires reporting of Clinical lab prices and volumes. MCHS requested a delay in the reporting, and changes to expand the definition of applicable lab to represent the true market of all laboratories; requested greater transparency of calculations; more time to allow for gathering data and implementation. Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,Veterans Affairs, Dept of (VA)   90000 0 0 2017-07-11T13:31:19.420000-04:00
1985148 THE CJR GROUP, INC. 68954119-41a2-4b7b-8708-2fdf11ba6fce Q2 THE CJR GROUP, INC. 288293 UNIVERSITY HOSPITALS HEALTH SYSTEM 2017 second_quarter MED Issues impacting hospitals HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2017-07-11T14:52:54.617000-04:00
1985383 TCH GROUP, LLC 5d20535e-71af-4a87-a081-c26e06aa9565 Q2 TCH GROUP, LLC 51478 INTERNATIONAL AIDS VACCINE INITIATIVE 2017 second_quarter MED FY 18 House and Senate State Foreign Operations Subcommittee Appropriations bill. Specifically, continued Federal funding under USAID for AIDS vaccine research and development HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2017-07-11T18:31:50.540000-04:00
1985518 WILLIAMS AND JENSEN, PLLC bdffe766-a3dd-4d68-81da-d6464b35cc72 Q2 WILLIAMS AND JENSEN, PLLC 41454 MT PHARMA AMERICA, INC. 2017 second_quarter MED Matters affecting access to and pricing of pharmaceuticals; matters affecting the Orphan Drug Act. HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2017-07-12T09:54:32.433000-04:00
1985737 PHARMA & BIOPHARMA OUTSOURCING ASSOCIATION 79a793b2-d4ff-4634-a1f5-7cefadd3a99e Q2 PHARMA & BIOPHARMA OUTSOURCING ASSOCIATION 401103605 PHARMA & BIOPHARMA OUTSOURCING ASSOCIATION 2017 second_quarter MED Lobbied for timely passage of FDA Reauthorization Act (H.R. 2430, S. 934), and provided general education about the pharma/biopharma contract services sector. HOUSE OF REPRESENTATIVES,SENATE   50000 0 0 2017-07-12T12:28:16.063000-04:00
1985765 AMERICAN SOCIETY FOR CLINICAL PATHOLOGY c5fb69ac-cf8d-4b42-b495-ed32d87b1c19 Q2 AMERICAN SOCIETY FOR CLINICAL PATHOLOGY 3435 AMERICAN SOCIETY FOR CLINICAL PATHOLOGY 2017 second_quarter MED Affordable Care Act; Medicare; Electronic Health Records; Health Information Technology; Medicare Access and CHIP Reauthorization Act; Protecting Access to Care Act; Medicare Physician and Clinical Laboratory Fee Schedules; Physician Quality Reporting System; Medicare Local Coverage Determination Reform; Medical Devices (Laboratory Tests); Stark Self-Referral Reform; Physician and Allied Health Shortages and Education; Appropriations for Federal Health Agencies; Global Health Initiative; Non-Communicable Diseases Agency for Healthcare Research & Quality (AHRQ),Bureau of Labor Statistics (BLS),Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Congressional Budget Office (CBO),Food & Drug Administration (FDA),Government Accountability Office (GAO),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Labor, Dept of (DOL),Medicare Payment Advisory Commission (MedPAC),Natl Institutes of Health (NIH),Office of Management & Budget (OMB),Office of Personnel Management (OPM),Office of Science & Technology Policy (OSTP),SENATE,State, Dept of (DOS),Veterans Affairs, Dept of (VA),White House Office   49000 0 0 2017-07-12T12:57:51.493000-04:00
1985833 LEAVITT PARTNERS, LLC 19c1502f-59c0-4a87-a26e-2f59b13fdecc Q2 LEAVITT PARTNERS, LLC 401103367 510(K) COALITION 2017 second_quarter MED Medical Device regulation HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2017-07-12T13:20:04.923000-04:00
1985880 THE O TEAM LLC a942ea29-21e5-4da9-a6dd-ebcdcddb9b48 Q2 THE O TEAM LLC 400783359 THE SUZANNE WRIGHT FOUNDATION 2017 second_quarter MED Pancreatic cancer awareness. HOUSE OF REPRESENTATIVES,SENATE 90000   0 0 2017-07-12T13:41:56.247000-04:00
1986273 MCDERMOTT+ LLC d304b6ab-6856-46d3-8906-589d2394bf75 Q2 MCDERMOTT+ LLC 401103287 COALITION FOR 21ST CENTURY MEDICINE 2017 second_quarter MED Issues concerning regulation of laboratory-developed tests. Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE 80000   0 0 2017-07-13T10:17:51.520000-04:00
1986327 RAY C CULVER III 28b26584-3b43-4290-8349-6973ac80f152 Q2 RAY C CULVER III 11468 ARKANSAS CHILDREN'S HOSPITAL 2017 second_quarter MED Funding for the USDA Agricultural Research Service human nutrition research centers in both the FY17 Agricultural Appropriations bill (currently PL 114-254) and FY18 Agricultural Appropriations bills. HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2017-07-13T10:39:36.703000-04:00
1986440 THE PETRIZZO GROUP, INC. 854de04f-cd3e-444c-995a-8075d047fbc0 Q2 THE PETRIZZO GROUP, INC. 305932 FRED HUTCHINSON CANCER RESEARCH CENTER 2017 second_quarter MED Advocated for increased funding for NIH and NCI. Advocated for precision medicine and precision oncology issues. Advocated for clinical research administrative reforms. Advocated against any reductions to indirect cost reimbursement rates provided by NIH. HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2017-07-13T11:25:55.317000-04:00
1986452 THE PETRIZZO GROUP, INC. ec093fbd-dc93-4cac-b64d-3b2e3dc95924 Q2 THE PETRIZZO GROUP, INC. 305932 ALLEN INSTITUTE 2017 second_quarter MED Advocated for funding of the BRAIN Initiative and full funding for NIH. Advocated for the development of open data hosting, and integrated, scalable data analysis hubs for the BRAIN Initiative at NIH. HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2017-07-13T11:27:01.987000-04:00
1986475 THE PETRIZZO GROUP, INC. 36f76b15-c0e8-4c5b-a97f-36ccd969955b Q2 THE PETRIZZO GROUP, INC. 305932 OMEROS CORPORATION 2017 second_quarter MED Advocated for Medicare packaged payment reform in Part B. HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2017-07-13T11:32:23.360000-04:00
1986655 PARRY, ROMANI, DECONCINI & SYMMS 04330c24-d570-416c-8ee5-5b960116827a Q2 PARRY, ROMANI, DECONCINI & SYMMS 30792 AIDS HEALTHCARE FOUNDATION 2017 second_quarter MED Department of Labor, Health, Human Services, and Education, and Related Agencies Appropriations Act, FY 2018 - Support funding for medical treatments for HIV positive patients. Support appropriate funding for the ADAP program. HOUSE OF REPRESENTATIVES,SENATE 36000   0 0 2017-07-13T13:48:12.973000-04:00
1986714 GRIZZLE COMPANY 88e988c0-d8cd-4b8f-9f2f-25e533de0610 Q2 GRIZZLE COMPANY 16987 UNIVERSITY OF LOUISVILLE 2017 second_quarter MED Request letters of support for grant application to the NIMHD. HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2017-07-13T14:33:00.727000-04:00
1986811 NELSON MULLINS RILEY & SCARBOROUGH 58cda2a3-43ea-4416-80c9-2a1c62c1aaac Q2 NELSON MULLINS RILEY & SCARBOROUGH 285871 NATERA, INC. 2017 second_quarter MED Biomedical research, maternal health, and genetic testing HOUSE OF REPRESENTATIVES,SENATE     0 0 2017-07-13T15:17:10.513000-04:00
1987189 CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER f3e15d53-fdc6-431b-a375-c2a9fc486326 Q2 CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER 312496 CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER 2017 second_quarter MED NIH funding HHS budget bill, PREA re-authorization, cancer moonshot Agency for Healthcare Research & Quality (AHRQ),Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE   65597 0 0 2017-07-14T09:50:53.123000-04:00
1987465 O'NEILL AND ASSOCIATES 9d0f8e86-66f7-467e-9b08-d938f6d8f532 Q2 O'NEILL AND ASSOCIATES 73134 POINT32HEALTH SERVICES, INC. (FORMERLY TUFTS HEALTH PLAN) 2017 second_quarter MED Medicare advantage and health care reform HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2017-07-14T12:28:56.707000-04:00
1987763 HACKENSACK MERIDIAN HEALTH 9e4cb324-80e0-443d-b5ad-aa4d67acbf26 Q2 HACKENSACK MERIDIAN HEALTH 401104109 HACKENSACK MERIDIAN HEALTH 2017 second_quarter MED National Institutes of Health funding Behavioral health Substance abuse, opioids, and patient data Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,Veterans Affairs, Dept of (VA)   40000 0 0 2017-07-14T14:54:14.183000-04:00
1987774 AMERICAN OSTEOPATHIC ASSOCIATION de94c557-2fec-4513-a8eb-f05e69eb5657 Q2 AMERICAN OSTEOPATHIC ASSOCIATION 3014 AMERICAN OSTEOPATHIC ASSOCIATION 2017 second_quarter MED NIH; FDA Agency for Healthcare Research & Quality (AHRQ),Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Executive Office of the President (EOP),Food & Drug Administration (FDA),Government Accountability Office (GAO),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Medicare Payment Advisory Commission (MedPAC),Office of Management & Budget (OMB),SENATE,White House Office   291476 0 0 2017-07-14T14:56:16.060000-04:00
1987857 THE FRIEDLANDER GROUP 509fd64e-9096-4285-bb11-d81949fbf73a Q2 THE FRIEDLANDER GROUP 400535604 OHEL CHILDRENS HOME AND FAMILY SERVICES 2017 second_quarter MED Block Grants HOUSE OF REPRESENTATIVES,SENATE 7500   0 0 2017-07-14T15:29:37.580000-04:00
1987936 HOLLAND & KNIGHT LLP 26d88045-a41a-42d0-b6b2-801894062fdf Q2 HOLLAND & KNIGHT LLP 18466 THE BIOSIMILARS FORUM 2017 second_quarter MED Medicare reimbursement issues, FDA regulation of biosimilars; S. 934, H.R. 2430, the FDA Reauthorization Act of 2017. Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE 120000   0 0 2017-07-14T15:53:47.137000-04:00
1987957 P STREET PROJECT, INC. 32c805e4-da7f-4fe7-9934-2cbbf01adb75 Q2 P STREET PROJECT, INC. 400637928 P STREET PROJECT, INC. 2017 second_quarter MED Public health insurance option and Medicare for All; advocating against repeal of ACA HOUSE OF REPRESENTATIVES,SENATE   20000 0 0 2017-07-14T16:15:02.727000-04:00
1988320 BROYDRICK & ASSOCIATES d6f9e7cf-6991-412e-ba3e-1bfa014dd19c Q2 BROYDRICK & ASSOCIATES 7268 EXACT SCIENCES 2017 second_quarter MED Legislation on cancer screening test process. Agency for Healthcare Research & Quality (AHRQ),Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,Office of Personnel Management (OPM),SENATE 50000   0 0 2017-07-16T19:55:46.990000-04:00
1988330 BROYDRICK & ASSOCIATES b974aa07-a0db-42da-a51f-09f00a44a124 Q2 BROYDRICK & ASSOCIATES 7268 MORTARA INSTRUMENTS, INC. 2017 second_quarter MED OFAC licensing. Vender-neutral procurement language. 21st Century cures and E.H.R. interoperability. Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE     0 0 2017-07-16T20:02:58.570000-04:00
1988332 BROYDRICK & ASSOCIATES 22804e0e-70f5-4659-a126-76cf5cca1d94 Q2 BROYDRICK & ASSOCIATES 7268 NORTHSTAR RADIOISOTOPES, LLC 2017 second_quarter MED DOE policies and cooperative agreements expansion legislation. Nuclear medicine and CMS Reimbursement. NNSA reorganization, S512 Uranium production (2017). DOE appropriations. Energy, Dept of,HOUSE OF REPRESENTATIVES,SENATE     0 0 2017-07-16T20:04:02.320000-04:00
1988413 SRI INTERNATIONAL 451b2a1f-6571-425e-a61c-e143867043aa Q2 SRI INTERNATIONAL 90990 SRI INTERNATIONAL 2017 second_quarter MED FY18 Labor-HHS-Education Appropriations HOUSE OF REPRESENTATIVES,SENATE   8000 0 0 2017-07-17T09:11:48.287000-04:00
1988648 PODESTA GROUP, INC. 983597ff-6fcf-4ec9-8488-7e4a37fdebd9 2T PODESTA GROUP, INC. 31680 UNIVERSITY OF MIAMI 2017 second_quarter MED Federal funding for spinal cord injury research. Health research funding. Department of Defense Appropriations. HOUSE OF REPRESENTATIVES,SENATE 30000   0 1 2017-07-17T10:34:37.047000-04:00
1988667 PARALYZED VETERANS OF AMERICA c168a830-ae6d-4ba6-a3c3-92e2ace1555b Q2 PARALYZED VETERANS OF AMERICA 30724 PARALYZED VETERANS OF AMERICA 2017 second_quarter MED Department of Veterans Affairs, Medical Research Issues National Institutes of Health, Medical Research Issues HOUSE OF REPRESENTATIVES,Justice, Dept of (DOJ),Natl Institutes of Health (NIH),SENATE,Veterans Affairs, Dept of (VA)   82957 0 0 2017-07-17T10:35:47.187000-04:00
1989143 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 786bd2c3-cd22-4457-8f09-a26a0dc32c99 Q2 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 ENDOCRINE SOCIETY 2017 second_quarter MED Research in Endocrinology Centers For Medicare and Medicaid Services (CMS),Environmental Protection Agency (EPA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 30000   0 0 2017-07-17T13:03:18.757000-04:00
1989155 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 99461f34-0edf-49ff-bb35-8bb4cbbd0703 Q2 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 AMERICAN SOCIETY OF HEMATOLOGY 2017 second_quarter MED Research in hematology; legislation to enhance federal efforts on research training and services for sickle cell disease; HR 2410 SCD Research, Surveillance Prevention and Treatment Act of 2017 Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 30000   0 0 2017-07-17T13:07:24.303000-04:00
1989163 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. f330ee14-120f-4f0c-80dd-907a2abf7929 Q2 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 NATIONAL HEMOPHILIA FOUNDATION 2017 second_quarter MED Hemophilia research, prevention, surveillance and service programs and issues. Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 50000   0 0 2017-07-17T13:10:29.507000-04:00
1989172 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 608b3b91-7921-416a-bfad-dc09258a4834 Q2 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 NATIONAL ASSOCIATION OF EPILEPSY CENTERS 2017 second_quarter MED Research and public health programs in epilepsy. Agency for Healthcare Research & Quality (AHRQ),Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 10000   0 0 2017-07-17T13:11:30.647000-04:00
1989496 FAEGRE DRINKER BIDDLE & REATH LLP 7a11213e-4825-4d20-bb33-172453dd005e 2T FAEGRE DRINKER BIDDLE & REATH LLP 12631 ALLIANCE FOR BIOSECURITY 2017 second_quarter MED S. 2055 Medical Countermeasure Innovations Act of 2015 provision regarding priority review vouchers contracting; H.R. 34 21st Century Cures Act; H.R. 3299, Strengthening Public Health Emergency Response Act of 2016, provisions regarding priority review vouchers contracting. Centers For Disease Control & Prevention (CDC),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE 20000   0 1 2017-07-17T14:39:17.580000-04:00
1989725 MAGNET STRATEGY GROUP f355b10c-bac1-4a48-a6a6-6a103e0fbc28 Q2 MAGNET STRATEGY GROUP 401104125 MEDICAGO INC. 2017 second_quarter MED Importance of biopharmaceutical platforms to strengthen preparedness against future outbreaks in emerging infectious disease. HOUSE OF REPRESENTATIVES,SENATE 7000   0 0 2017-07-17T15:07:33.333000-04:00
1989762 ALEXION PHARMACEUTICALS, INC. be46da7c-fb01-4468-8026-f1de499c2bef Q2 ALEXION PHARMACEUTICALS, INC. 400504482 ALEXION PHARMACEUTICALS, INC. 2017 second_quarter MED PDUFA Reauthorization Right-to-Try Legislation RACE for Children Act HOUSE OF REPRESENTATIVES,SENATE   299245 0 0 2017-07-17T15:14:56.100000-04:00
1989933 FAEGRE DRINKER BIDDLE & REATH LLP 48e0ff8a-b2a3-42ed-a2db-9014b79a8fc4 Q2 FAEGRE DRINKER BIDDLE & REATH LLP 12631 AMERICAN SOCIETY OF TROPICAL MEDICINE AND HYGIENE 2017 second_quarter MED Public Health Programs for Infectious and Tropical Disease; NIH Research; Issues related to government agency conference travel; Draft domestic neglected tropical disease legislation. Centers For Disease Control & Prevention (CDC),HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2017-07-17T15:54:10.557000-04:00
1989982 FRANCIS EDWARD & CRONIN, INC. 93223273-9125-4faa-9d14-fb471c4632d0 2A FRANCIS EDWARD & CRONIN, INC. 311314 PATH DECISION SUPPORT SOFTWARE, LLC 2017 second_quarter MED Issues and legislation related to diabetes diagnosis and treatment. HOUSE OF REPRESENTATIVES,SENATE 5000   0 0 2017-07-17T15:56:21.917000-04:00
1990056 KD ADVOCACY AND CONSULTING, LLC babba992-67b1-4ece-8ca5-45588e0a1f54 Q2 KD ADVOCACY AND CONSULTING, LLC 401103971 REACHING MILESTONES 2017 second_quarter MED Advocating to improve coverage and access to autism treatment services for TRICARE beneficiaries. Defense, Dept of (DOD)     0 0 2017-07-17T16:15:14.920000-04:00
1990503 THORN RUN PARTNERS 789a214d-661a-49d4-87d9-34e41d131bc2 Q2 THORN RUN PARTNERS 400534596 CONTINUING MEDICAL EDUCATION COALITION 2017 second_quarter MED Issues related to the promotion of continuing medical education (CME) and the implementation of the Physician Payment Sunshine Act. Implementation issues related to the Medicare Access and CHIP Reauthorization Act of 2015, P.L.114-10. Issues related to the role of continuing medical education (CME) and Food and Drug Administration (FDA) opioid REMS. Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2017-07-17T23:15:04.557000-04:00
1990512 THORN RUN PARTNERS 3e35f72f-e8e3-4ddf-b113-75c140760d3c Q2 THORN RUN PARTNERS 400534596 NOVARTIS CORPORATION 2017 second_quarter MED Issues related to biologics. HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2017-07-17T23:37:14.403000-04:00
1990523 CARDINAL HEALTH, INC. aa430653-7743-4083-9f6c-2d016cca9791 Q2 CARDINAL HEALTH, INC. 58055 CARDINAL HEALTH INC 2017 second_quarter MED H.R. 6: 21st Century Cures Act (entire bill) - implementation Medical Device Tax HOUSE OF REPRESENTATIVES,SENATE   360000 0 0 2017-07-17T23:54:10.717000-04:00
1990524 THORN RUN PARTNERS 7906c91d-d723-4ee2-a630-3adbb16a2be5 Q2 THORN RUN PARTNERS 400534596 CHILDRENS HOSPITAL COLORADO 2017 second_quarter MED H.R.1628, American Health Care Act of 2017/Better Care Reconciliation Act of 2017. Issues related to pediatric research and childrens hospital graduate medical education. Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2017-07-17T23:56:12.920000-04:00
1990528 THORN RUN PARTNERS a1d011a2-181d-482c-9cb6-d8033f5b82b5 Q2 THORN RUN PARTNERS 400534596 ABBOTT LABORATORIES 2017 second_quarter MED Issues related to coverage and reimbursement for durable medical equipment, medical devices, diagnostics and nutrition. HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2017-07-17T23:58:14.420000-04:00
1990593 THE NATIONAL ALLIANCE FOR EYE AND VISION RESEARCH a41c575e-8440-4db6-8fe4-560765b76d21 Q2 THE NATIONAL ALLIANCE FOR EYE AND VISION RESEARCH 314055 THE NATIONAL ALLIANCE FOR EYE AND VISION RESEARCH 2017 second_quarter MED Federal Support for the National Institutes of Health and the National Eye Institute HOUSE OF REPRESENTATIVES,SENATE   61406 0 0 2017-07-18T08:34:34.790000-04:00
1990677 THORN RUN PARTNERS ab4dcd5b-7b02-420f-a55e-59563fcdf7c5 Q2 THORN RUN PARTNERS 400534596 ABBVIE INC. 2017 second_quarter MED Issues related to National Institutes of Health (NIH), Centers for Disease Control (CDC), and other funding. Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2017-07-18T09:30:36.813000-04:00
1990745 TRAVERE THERAPEUTICS 06dd84cb-d3f6-4b91-8875-64ffcd0e3e1a Q2 TRAVERE THERAPEUTICS 401104190 TRAVERE THERAPEUTICS 2017 second_quarter MED Medical research, NIH funding, FDA personnel issues HOUSE OF REPRESENTATIVES,SENATE   140000 0 0 2017-07-18T09:55:26.940000-04:00
1990788 WINNING STRATEGIES WASHINGTON 4f95de11-7bf9-4531-b6d7-dba79ecde09c Q2 WINNING STRATEGIES WASHINGTON 50796 ALGOMETRX, INC. 2017 second_quarter MED Research and development of advanced pain assessment and diagnostic technology HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 10000   0 0 2017-07-18T10:03:54.147000-04:00
1990873 LNE GROUP d8c26b91-2806-49e3-a124-62441844436d Q2 LNE GROUP 308811 HOSPICE OF THE WESTERN RESERVE 2017 second_quarter MED Lobbied on issues related to medical/disease research. HOUSE OF REPRESENTATIVES,SENATE,Veterans Affairs, Dept of (VA) 30000   0 0 2017-07-18T10:26:54.273000-04:00
1990981 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. bf4ab19c-95ca-464b-a698-b11146c2a7a8 Q2 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 TUBEROUS SCLEROSIS ALLIANCE 2017 second_quarter MED Labor-HHS-Education Appropriations bill, Tuberous Sclerosis, research at the National Institutes of Health and the Centers for Disease Control and Prevention. FY 2017, Defense Appropriations, FY 2017 defense health program, Tuberous Sclerosis Complex Research Program HR 244, FY 17 Consolidated Appropriation Act, defense and NIH medical research HR 3219, FY 18 Defense Appropriations Act, Tuberous Sclerosis Medical Research program HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 30000   0 0 2017-07-18T10:49:57.603000-04:00
1991011 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. b858465c-6fff-4f4d-81a9-74c1f1837dc3 Q2 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 HEREDITARY HEMORRHAGIC TELANGIECTASIA FOUNDATION 2017 second_quarter MED Research opportunities at the Department of Defense and the Centers for Disease Control. FY 2017, Labor-HHS Appropriations Act, blood and bleeding disorders. FY 2017, Defense Appropriations Act, defense health programs. HR 1628, American Health Care Act, Medicaid and Essential Health Benefits HR 244, FY 17 Consolidated Appropriations Act, defense medical research and CDC funding for HHT surveillance HR 3219, FY 18 Defense Appropriations Act, defense medical research HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 10000   0 0 2017-07-18T10:58:20.573000-04:00
1991044 LNE GROUP 70b70818-e80b-4e01-9499-11f6ab3fd3d7 Q2 LNE GROUP 308811 PARKER HANNIFIN 2017 second_quarter MED Lobbied for issues related to medical research. HOUSE OF REPRESENTATIVES,SENATE 80000   0 0 2017-07-18T11:00:32.073000-04:00
1991059 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 6ab07f36-1d77-4da4-9a26-89129d5074b4 Q2 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 AMERICAN BRAIN TUMOR ASSOCIATION 2017 second_quarter MED FY 17, Defense Appropriations Act, cancer research, HR 1301 FY 17, Labor-HHS-Education Appropriations Act, S 3040/HR 5926 NIH, Cancer Research FY 18, Defense Appropriations Act, cancer research HR 244, FY 17 Consolidated Appropriations Act, defense medical research programs HR 3219, FY 18 Defense Appropriations Act, defense medical research programs Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 20000   0 0 2017-07-18T11:02:45.307000-04:00
1991063 THORN RUN PARTNERS 84a468d9-7605-469a-87dc-21949f99baa9 Q2 THORN RUN PARTNERS 400534596 GLAUKOS CORPORATION 2017 second_quarter MED Issues related to medical technology used for the treatment of glaucoma. HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2017-07-18T11:02:46.840000-04:00
1991343 PUBLIC SPHERE, INC. 91c4ef77-b1b7-4172-b663-d47795c65980 Q2 PUBLIC SPHERE, INC. 401104153 SI-BONE 2017 second_quarter MED General company overview for members and staff. Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2017-07-18T12:02:22.047000-04:00
1991479 CAPITOL HILL STRATEGIES, LLC 6badb757-014c-4e34-95f8-6c2a8575e1b6 Q2 CAPITOL HILL STRATEGIES, LLC 91774 BIOTECHNOLOGY INDUSTRY ORGANIZATION 2017 second_quarter MED H.R. 2430, the FDA Reauthorization Act (FDARA) of 2017, legislation to reauthorize the Prescription Drug User Fee Act (PDUFA), as reauthorized by the Food and Drug Administration Safety and Innovation Act of 2012 (FDASIA). HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2017-07-18T12:43:52.007000-04:00
1991496 CAPITOL HILL STRATEGIES, LLC 9c863313-bc09-450c-a38a-e682718e5be4 Q2 CAPITOL HILL STRATEGIES, LLC 91774 BIOGEN INC 2017 second_quarter MED Issues dealing with newborn screening. H.R. 2430, the FDA Reauthorization Act (FDARA) of 2017, legislation to reauthorize the Prescription Drug User Fee Act (PDUFA), as reauthorized by the Food and Drug Administration Safety and Innovation Act of 2012 (FDASIA). Issues dealing with Alzheimer's treatments HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2017-07-18T12:47:58.803000-04:00
1991512 ASSOCIATION FOR DIAGNOSTICS & LABORATORY MEDICINE (FORMERLY AACC) cade23e2-6ce0-4b5e-a2a5-31b8a08e9d47 Q2 ASSOCIATION FOR DIAGNOSTICS & LABORATORY MEDICINE (FORMERLY AACC) 1466 ASSOCIATION FOR DIAGNOSTICS & LABORATORY MEDICINE (FORMERLY AACC) 2017 second_quarter MED AACC met with House and Senate members and staff to express concerns about legislative efforts to extend Food and Drug Administration oversight to laboratory developed tests, which are currently regulated by the Centers for Medicare and Medicaid Services under CLIA'88. HOUSE OF REPRESENTATIVES,SENATE   80000 0 0 2017-07-18T12:49:03.083000-04:00
1991547 WINNING STRATEGIES WASHINGTON 5813cb73-2f83-4fe7-a724-541649ce066d Q2 WINNING STRATEGIES WASHINGTON 50796 HEALTHCARE INSTITUTE OF NEW JERSEY 2017 second_quarter MED Monitor Prescription Drug User Fee Act re-authorization HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2017-07-18T12:53:19.553000-04:00
1991563 AMERICAN PHYSICAL THERAPY ASSOCIATION e401708b-9a45-45c4-8cf7-4273546822d7 Q2 AMERICAN PHYSICAL THERAPY ASSOCIATION 3093 AMERICAN PHYSICAL THERAPY ASSOCIATION 2017 second_quarter MED NIH Rehab issues APTA role with NIH Traumatic brain injury research Support of work done at CDC Injury Center on elder adult falls, TBI, youth sports concussions NIH Research and Development funding AHRQ Quality measure development panel for hip fracture patients and fall risk in PAC Comments on Behavioral Counseling to Promote a Healthy Diet and Physical Activity for Cardiovascular Disease Prevention in Adults with Known Risk Factors PT role in childhood obesity Relocate TBI State Grant Program to ACL SAFE PLAY Act Agency for Healthcare Research & Quality (AHRQ),Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),Education, Dept of,Government Accountability Office (GAO),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Medicare Payment Advisory Commission (MedPAC),Natl Institutes of Health (NIH),Office of Management & Budget (OMB),SENATE,Small Business Administration (SBA),Veterans Affairs, Dept of (VA),White House Office   246629 0 0 2017-07-18T12:57:29.147000-04:00
1991577 THORN RUN PARTNERS bd07793f-b513-4293-8162-c71cf216655d Q2 THORN RUN PARTNERS 400534596 HACKENSACK MERIDIAN HEALTH 2017 second_quarter MED H.R.1628, American Health Care Act of 2017/Better Care Reconciliation Act of 2017. Issues relating to research funding, NIH and other matters. HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2017-07-18T13:00:22.657000-04:00
1991735 AMERICAN ASSOCIATION OF ORTHOPAEDIC SURGEONS eb065a38-58d3-4a9f-9111-656d9a5ab024 Q2 AMERICAN ASSOCIATION OF ORTHOPAEDIC SURGEONS 52105 AMERICAN ASSOCIATION OF ORTHOPAEDIC SURGEONS 2017 second_quarter MED Work to enhance funding for NIH. Support funding for the Peer Reviews Orthopaedic Research Program HOUSE OF REPRESENTATIVES,SENATE   461408 0 0 2017-07-18T13:40:24.760000-04:00
1991765 WINNING STRATEGIES WASHINGTON 369d0c91-3fdd-43a7-9fd7-2ffec8631bba Q2 WINNING STRATEGIES WASHINGTON 50796 LAHEY HEALTH 2017 second_quarter MED Rural wage index Medicare Reform HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2017-07-18T13:41:36.950000-04:00
1991854 UNIVERSITY OF MIAMI c85e5b7b-db90-4f88-8d6a-4367c2bf097d Q2 UNIVERSITY OF MIAMI 39462 UNIVERSITY OF MIAMI 2017 second_quarter MED Department of Defense Appropriations. Defense, Dept of (DOD)   108032 0 0 2017-07-18T13:54:43.077000-04:00
1992222 WEBMD HEALTH CORP. 9a3d04f6-67b9-438a-90d9-33d856c1a7c3 Q2 WEBMD HEALTH CORP. 55473 WEBMD HEALTH CORP 2017 second_quarter MED Explore partnership opportunities with the government to disseminate healthcare and research information to physicians and consumers. Federal health care reform efforts; Privacy, security and confidentiality issues; Direct to consumer advertising; Wellness programs and incentives for creation of such programs; Pharma issues related to both advertising and deduction of expenses associated with advertising; Personal health records. HOUSE OF REPRESENTATIVES,SENATE   10000 0 0 2017-07-18T14:48:59.487000-04:00
1992244 AMERICAN ACADEMY OF PEDIATRICS 3b37bd1c-a31c-472b-ad10-b286afe73a79 Q2 AMERICAN ACADEMY OF PEDIATRICS 1397 AMERICAN ACADEMY OF PEDIATRICS 2017 second_quarter MED Fetal Tissue Research Environmental influences on Child Health Outcomes Drugs and Devices Administration for Children & Families (ACF),Agriculture, Dept of (USDA),Centers For Disease Control & Prevention (CDC),Consumer Product Safety Commission (CPSC),Education, Dept of,Environmental Protection Agency (EPA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Indian Health Service,Office of Management & Budget (OMB),SENATE,State, Dept of (DOS),Transportation, Dept of (DOT),U.S. Agency for International Development (USAID),White House Office 90271   0 0 2017-07-18T14:51:15.130000-04:00
1992281 AMERICAN ACADEMY OF PEDIATRICS 5142711e-4231-4e00-a553-0e2ffeeb7484 2A AMERICAN ACADEMY OF PEDIATRICS 1397 AMERICAN ACADEMY OF PEDIATRICS 2017 second_quarter MED Fetal Tissue Research Environmental influences on Child Health Outcomes Drugs and Devices Administration for Children & Families (ACF),Agriculture, Dept of (USDA),Centers For Disease Control & Prevention (CDC),Consumer Product Safety Commission (CPSC),Education, Dept of,Environmental Protection Agency (EPA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Indian Health Service,Office of Management & Budget (OMB),SENATE,State, Dept of (DOS),Transportation, Dept of (DOT),U.S. Agency for International Development (USAID),White House Office 90271   0 0 2017-07-18T14:54:34.147000-04:00
1992342 AMERICAN ACADEMY OF PEDIATRICS 9af3226d-58c9-4a53-aac6-ddca5787628c 2A AMERICAN ACADEMY OF PEDIATRICS 1397 AMERICAN ACADEMY OF PEDIATRICS 2017 second_quarter MED Fetal Tissue Research Environmental influences on Child Health Outcomes Drugs and Devices Administration for Children & Families (ACF),Agriculture, Dept of (USDA),Centers For Disease Control & Prevention (CDC),Consumer Product Safety Commission (CPSC),Education, Dept of,Environmental Protection Agency (EPA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Indian Health Service,Office of Management & Budget (OMB),SENATE,State, Dept of (DOS),Transportation, Dept of (DOT),U.S. Agency for International Development (USAID),White House Office     0 0 2017-07-18T14:58:02.350000-04:00
1993590 CHILDREN'S HOSPITAL AND HEALTH SYSTEM, INC. 9793f7dc-0680-47aa-821e-2f9863c5fc75 Q2 CHILDREN'S HOSPITAL AND HEALTH SYSTEM, INC. 401103415 CHILDREN'S HOSPITAL AND HEALTH SYSTEM, INC. 2017 second_quarter MED Implementation of the 21st Century Cures Act, provisions related to pediatric training and research. Establishment of a pediatric program office or coordinating council at the National Institutes of Health. HOUSE OF REPRESENTATIVES,SENATE   110000 0 0 2017-07-18T18:49:53.267000-04:00
1993591 FTI GOVERNMENT AFFAIRS 5f9cf962-0c5c-47e6-864a-2e13a7f05d5c Q2 FTI GOVERNMENT AFFAIRS 401054971 HUDSONALPHA INSTITUTE FOR BIOTECHNOLOGY 2017 second_quarter MED Monitor developments related to Electronic Health Records. HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2017-07-18T18:50:54.610000-04:00
1994151 WILLIAMS AND JENSEN, PLLC 9037f7a7-e017-4f54-ab88-6debbe51f526 Q2 WILLIAMS AND JENSEN, PLLC 41454 VERTEX PHARMACEUTICALS INCORPORATED 2017 second_quarter MED Prescription drug user fee agreements and general education about FDA approval policies and NIH research activities. HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2017-07-19T08:47:33.303000-04:00
1994156 WILLIAMS AND JENSEN, PLLC 67d6a289-8794-464b-baab-9c8e74a45dcf Q2 WILLIAMS AND JENSEN, PLLC 41454 BIOGEN IDEC 2017 second_quarter MED Prescription drug user fee agreements and general education about FDA approval polices and NIH research activities. Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2017-07-19T08:48:36.117000-04:00
1994286 WASHINGTON STATE UNIVERSITY de44bd97-549f-491a-aa6a-003c694ba192 Q2 WASHINGTON STATE UNIVERSITY 40657 WASHINGTON STATE UNIVERSITY 2017 second_quarter MED Medical Education, antimicrobial resistance Centers For Disease Control & Prevention (CDC),Defense, Dept of (DOD),Education, Dept of,Energy, Dept of,HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),Natl Science Foundation (NSF),Office of Science & Technology Policy (OSTP),SENATE,White House Office   60040 0 0 2017-07-19T09:22:02.730000-04:00
1994554 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 518acb73-6ae4-416d-9d29-987a91550bad Q2 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 23ANDME, INC. 2017 second_quarter MED Direct to consumer genetic testing Regulation and oversight of diagnostics Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Science & Technology Policy (OSTP),SENATE 20000   0 0 2017-07-19T10:17:13.330000-04:00
1994569 TRAVERE THERAPEUTICS 030a4f97-e7a9-4db6-9177-e55b11420a48 2A TRAVERE THERAPEUTICS 401104190 TRAVERE THERAPEUTICS 2017 second_quarter MED Medical research, NIH funding, FDA personnel issues HOUSE OF REPRESENTATIVES,SENATE   170000 0 0 2017-07-19T10:19:20.580000-04:00
1994628 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. d3f72a8c-7060-4b88-9b0a-9ce403cda293 2T CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 CURE FORWARD 2017 second_quarter MED Cancer Moonshot Patient Access to lab results HOUSE OF REPRESENTATIVES,SENATE 20000   0 1 2017-07-19T10:25:54.940000-04:00
1994721 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. ba687529-6126-4614-b25f-73879c887456 Q2 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 ASSOCIATION FOR MOLECULAR PATHOLOGY 2017 second_quarter MED Regulation of laboratory diagnostics No bill number, Diagnostic Accuracy and Innovation Act Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Science & Technology Policy (OSTP),SENATE,White House Office 60000   0 0 2017-07-19T10:39:06.127000-04:00
1994922 BUCHANAN INGERSOLL & ROONEY PC dc95950d-8027-43bc-9ddf-b917ef1e2801 Q2 BUCHANAN INGERSOLL & ROONEY PC 55291 WOMEN'S CHOICE PHARMACEUTICALS, LLC 2017 second_quarter MED Development of government relations strategy relating to prenatal dietary supplements. HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2017-07-19T11:00:03.663000-04:00
1995026 LOBBYIT.COM 6e35d114-0f45-49ad-b0dc-75a9eb6b2d01 Q2 LOBBYIT.COM 400487397 BLADDER CANCER ADVOCACY NETWORK 2017 second_quarter MED Increase awareness of bladder cancer. Advocate in support of a bladder cancer specific direct line of funding within the CDMRP, designating May as "Bladder Cancer Awareness Month". HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2017-07-19T11:12:11.647000-04:00
1995125 UNIVERSITY OF IOWA b5860689-908c-40d3-85eb-941e77cd48c8 Q2 UNIVERSITY OF IOWA 49191 UNIVERSITY OF IOWA 2017 second_quarter MED Support for all federal agencies that fund medical and disease research FY 17 and FY 18 appropriations for HHS, NIH, CDC, and DOD FY 17 and FY 18 appropriations for Injury Prevention Centers at CDC Administration for Children & Families (ACF),Agriculture, Dept of (USDA),Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),Education, Dept of,Energy, Dept of,Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),Office of Management & Budget (OMB),SENATE,State, Dept of (DOS),Transportation, Dept of (DOT)   86662 0 0 2017-07-19T11:19:05.057000-04:00
1995477 AMERICAN SOCIETY OF HEMATOLOGY 382d4926-58fa-4730-bc26-42da7b881ff5 Q2 AMERICAN SOCIETY OF HEMATOLOGY 59171 AMERICAN SOCIETY OF HEMATOLOGY 2017 second_quarter MED Sickle Cell Disease/Trait Issues Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2017 (H.R. 2410) Hematology/Oncology Treatment Issues General Hematology Public Health and Research Issues Clinical Trials Regulations Regulation of Laboratory Developed Tests Cancer "Moonshot" Initiative Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE   30000 0 0 2017-07-19T11:48:59.637000-04:00
1995528 AMERICAN ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS b1b9e335-bd31-4dba-83f9-bf4cfe01f8a0 Q2 AMERICAN ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS 1672 AMERICAN ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS 2017 second_quarter MED Advocating in support of increased NIH funding in the FY 2018 Labor-HHS-Education Appropriations bill. Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE   138197 0 0 2017-07-19T11:54:31.293000-04:00
1995654 SQUIRE PATTON BOGGS 3a4a27e7-ccdf-4121-80d2-0c808269c4ac Q2 SQUIRE PATTON BOGGS 30906 UNIVERSITY OF GEORGIA 2017 second_quarter MED Traumatic brain injury research, funding, and outreach opportunities. Zika research funding. Agriculture, Dept of (USDA),Commerce, Dept of (DOC),Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,State, Dept of (DOS) 40000   0 0 2017-07-19T12:12:01.873000-04:00
1995685 HOGAN LOVELLS US LLP 79540839-e5e0-474d-967f-91cc1d46a7f5 Q2 HOGAN LOVELLS US LLP 18422 COLDCHAIN TECHNOLOGY SERVICES 2017 second_quarter MED Pursuing opportunities for better logistical application for storage and delivery of vaccines. HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2017-07-19T12:16:28.373000-04:00
1996418 VAN SCOYOC ASSOCIATES 1d21c9af-f1d3-4d7d-9053-ff8f5242eb89 Q2 VAN SCOYOC ASSOCIATES 39837 UNIVERSITY OF NOTRE DAME 2017 second_quarter MED Zika virus research and development related issues HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2017-07-19T13:39:53.493000-04:00
1996574 LOCKRIDGE, GRINDAL, NAUEN, PLLP d5b7652a-1228-474f-94f5-68e042e8b68f Q2 LOCKRIDGE, GRINDAL, NAUEN, PLLP 23053 HENNEPIN COUNTY MEDICAL CENTER 2017 second_quarter MED FY2018 Authorizations, Appropriations, and Budget Policy HOUSE OF REPRESENTATIVES,SENATE     0 0 2017-07-19T13:50:24.387000-04:00

Next page

Advanced export

JSON shape: default, array, newline-delimited, object

CSV options:

CREATE TABLE lobbying_activities (
            id INTEGER PRIMARY KEY,
            filing_uuid TEXT NOT NULL,
            filing_type TEXT NOT NULL,
            registrant_name TEXT NOT NULL,
            registrant_id INTEGER,
            client_name TEXT NOT NULL,
            filing_year INTEGER NOT NULL,
            filing_period TEXT NOT NULL,
            issue_code TEXT,
            specific_issues TEXT,
            government_entities TEXT,
            income_amount INTEGER,
            expense_amount INTEGER,
            is_no_activity INTEGER DEFAULT 0,
            is_termination INTEGER DEFAULT 0,
            received_date TEXT,
            CONSTRAINT fk_activity_filing FOREIGN KEY (filing_uuid)
                REFERENCES lobbying_filings_raw(filing_uuid)
        );
CREATE INDEX idx_act_client_name ON lobbying_activities(client_name COLLATE NOCASE);
CREATE INDEX idx_act_issue_code ON lobbying_activities(issue_code);
CREATE INDEX idx_act_filing_year ON lobbying_activities(filing_year);
CREATE INDEX idx_act_filing_uuid ON lobbying_activities(filing_uuid);
Powered by Datasette · Queries took 2948.956ms · Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API